US 6827926
Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
expired A61KA61K41/0071A61K49/0036
Quick answer
US patent 6827926 (Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy) held by Miravant Pharmaceuticals, Inc. expires Mon Dec 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Miravant Pharmaceuticals, Inc.
- Grant date
- Tue Dec 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 58
- CPC classes
- A61K, A61K41/0071, A61K49/0036, A61P, A61P17/00